A comprehensive review published in Precision Nutrition catalogues antileukemic activity across 53 mushroom species, spanning compounds that trigger cancer cell death, halt cell division, and stimulate immune responses against leukaemia cells. The mechanisms identified include apoptosis induction, cell cycle arrest, and modulation of key signalling pathways, with effects demonstrated primarily in laboratory and animal models. Clinical evidence remains sparse and preliminary,

Fungal-derived sacchachitosan, extracted from the medicinal mushroom Ganoderma lucidum, offers a sustainable and shellfish-free alternative to conventional chitosan for wound care applications.